Patents by Inventor Ludmila Frank

Ludmila Frank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9745557
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: August 29, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20150247131
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: May 15, 2015
    Publication date: September 3, 2015
    Inventors: Stefan GOLZ, Bernd KALTHOF, Svetlana MARKOVA, Ludmila FRANK, Eugene VYSOTSKI
  • Publication number: 20130115641
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: July 18, 2012
    Publication date: May 9, 2013
    Applicant: Bayer Intellectual Property GmbH
    Inventors: Stefan GOLZ, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Patent number: 8236540
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: August 7, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Patent number: 7879557
    Abstract: The invention relates to the nucleotide and amino acid sequences and to the activity and use of the fluorescent protein CGFP.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: February 1, 2011
    Assignee: Bayer Schering Pharma Aktiengsellschaft
    Inventors: Stefan Golz, Svetlana Markova, Ludmila Burakova, Ludmila Frank, Eugene Vysotski
  • Patent number: 7833749
    Abstract: The invention relates to the photoprotein mtClytin, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein mtClytin.
    Type: Grant
    Filed: September 3, 2004
    Date of Patent: November 16, 2010
    Assignee: Axxam S.p.A.
    Inventors: Stefan Golz, Svetlana Markova, Ludmila Burakova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20100184185
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 22, 2007
    Publication date: July 22, 2010
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20090203888
    Abstract: The invention relates to the photoprotein AQdecay, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein AQdecay.
    Type: Application
    Filed: May 3, 2006
    Publication date: August 13, 2009
    Inventors: Stefen Golz, Eugene Vysotski, Svetlana Markova, Galina A. Stepanyuk, Ludmila Frank
  • Publication number: 20070275377
    Abstract: The invention relates to the photoprotein mtClytin, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein mtClytin.
    Type: Application
    Filed: September 3, 2004
    Publication date: November 29, 2007
    Applicant: Bayer HealthCare AG
    Inventors: Stefan Golz, Svetlana Markova, Ludmila Burakova, Ludmila Frank, Eugene Vysotski
  • Patent number: 7297483
    Abstract: This invention relates to an isolated nucleic acid molecule which is a) a nucleic acid molecule comprising SEQ ID No. 3, or b) a nucleic acid molecule which exhibits at least 90% sequence identity to the nucleic acid molecule of SEQ ID No. 3, and the claimed nucleic acid molecule encodes luciferase. It also relates to an expression vector and to a transformed host cell.
    Type: Grant
    Filed: November 22, 2001
    Date of Patent: November 20, 2007
    Assignee: Bayer Aktiengesellschaft
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20070042375
    Abstract: The invention relates to the photoprotein berovin, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein berovin.
    Type: Application
    Filed: August 13, 2004
    Publication date: February 22, 2007
    Applicant: BAYER HEALTHCARE AG
    Inventors: Stefan Golz, Svetlana Markova, Ludmila Burakova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20060188930
    Abstract: The invention relates to the nucleotide and amino acid sequences and to the activity and use of the fluorescent protein CGFP.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 24, 2006
    Inventors: Stefan Golz, Svetlana Markova, Ludmila Burakova, Ludmila Frank, Eugene Vysottski
  • Publication number: 20040219527
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 1, 2003
    Publication date: November 4, 2004
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski